Tisk…

Anti-HLA-DRA Mouse Monoclonal Antibody (Biotin) [clone: IPO-10]

Dodavatel: Biotium
BNCB1090-500 BNCB1090-100
BNCB1090-500EA 15090 CZK
BNCB1090-500 BNCB1090-100
Anti-HLA-DRA Mouse Monoclonal Antibody (Biotin) [clone: IPO-10]
Protilátky
MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Type: Primary
Antigen: HLA-DRA
Clonality: Monoclonal
Clone: IPO-10
Conjugation: Biotin
Epitope:
Host: Mouse
Isotype: IgG3 kappa
Reactivity: Human, Monkey
Objednat

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Více About VWR